The silent killer after transplant: What you need to know about graft-versus-host disease
Understanding Graft-Versus-Host Disease (GVHD) Graft-versus-host disease (GVHD) is a severe complication that can occur after an allogeneic stem cell or bone marrow transplant. This condition ... Read More
Niktimvo FDA approval brings new hope for chronic graft-versus-host disease patients
The U.S. Food and Drug Administration (FDA) has approved Niktimvo (axatilimab-csfr), an anti-CSF-1R antibody, for treating chronic graft-versus-host disease (GVHD) in patients who have not ... Read More